Partner with Investors Who Understand the Science

Kaleida Capital backs early-stage founders at the frontier of neuroscience, AI, and human performance.

We are technical investors — scientists first, investors second — who work closely with mission-driven teams at the edge of what’s possible.

What We Look For:

Scientist in protective gear using a pipette to transfer liquid into test tubes in a laboratory, with lab equipment and microscope in the background.

  • U.S.-based companies with roots in world-class research (Stanford, MIT, UCSF, Harvard, etc.)

  • Strong technical IP with clear regulatory or clinical pathways

  • Pre-seed or seed-stage, sub-$25M post-money

  • Categories: Neural Interfaces, AI for Biology, Human Augmentation, Computational Diagnostics

  • Founders who value precision, narrative discipline, and true partnership

What You’ll Get:

Ariane Tom, Founder of Kaleida Capital, speaking at LSI USA 2024

  • Hands-on guidance in capital strategy, storytelling, and strategic partnerships

  • Access to a growing network of domain investors, family offices, and technologists

  • A partner who can translate between science, business, and market timing